Von Hoff DD - Search Results

1

Phase II trial of recombinant beta interferon in advanced colorectal cancer.

Lillis PK, Brown TD, Beougher K, Koeller J, Marcus SG, Von Hoff DD. Lillis PK, et al. Among authors: von hoff dd. Cancer Treat Rep. 1987 Oct;71(10):965-7. Cancer Treat Rep. 1987. PMID: 3308080 Clinical Trial.

2

Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).

Arteaga CL, Brown TD, Kuhn JG, Shen HS, O'Rourke TJ, Beougher K, Brentzel HJ, Von Hoff DD, Weiss GR. Arteaga CL, et al. Among authors: von hoff dd. Cancer Res. 1989 Aug 15;49(16):4648-53. Cancer Res. 1989. PMID: 2743343

3

A phase I clinical trial of recombinant DNA gamma interferon.

Brown TD, Koeller J, Beougher K, Golando J, Bonnem EM, Spiegel RJ, Von Hoff DD. Brown TD, et al. Among authors: von hoff dd. J Clin Oncol. 1987 May;5(5):790-8. doi: 10.1200/JCO.1987.5.5.790. J Clin Oncol. 1987. PMID: 3106584

4

Phase I study of alpha 2-interferon plus doxorubicin in patients with solid tumors.

Sarosy GA, Brown TD, Von Hoff DD, Spiegel RJ, Golando JP, Beougher KL, Kuhn JG, Kisner DL. Sarosy GA, et al. Among authors: von hoff dd. Cancer Res. 1986 Oct;46(10):5368-71. Cancer Res. 1986. PMID: 3756887

5

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies.

Burris HA 3rd, Raymond E, Awada A, Kuhn JG, O'Rourke TJ, Brentzel J, Lynch W, King SY, Brown TD, Von Hoff DD. Burris HA 3rd, et al. Among authors: von hoff dd. Invest New Drugs. 1998;16(1):19-27. doi: 10.1023/a:1016066529642. Invest New Drugs. 1998. PMID: 9740540 Clinical Trial.

6

A phase I clinical and pharmacokinetic trial of hepsulfam.

Ravdin PM, Havlin KA, Marshall MV, Brown TD, Koeller JM, Kuhn JG, Rodriguez G, Von Hoff DD. Ravdin PM, et al. Among authors: von hoff dd. Cancer Res. 1991 Dec 1;51(23 Pt 1):6268-72. Cancer Res. 1991. PMID: 1933887 Clinical Trial.

7

Doxorubicin and interferon: rationale and clinical experience.

Green MD, Speyer J, Wernz J, Kisner D, Koeller J, Blum R, Von Hoff D, Muggia F. Green MD, et al. Cancer Treat Rev. 1985 Dec;12 Suppl B:61-7. Cancer Treat Rev. 1985. PMID: 3833329 No abstract available.

8

Phase II study of carbetimer in non-small cell lung cancer.

Keaton M, Brown T, Craig J, Fries G, Harmon G, Zaloznik A, Orczyk G, Von Hoff D. Keaton M, et al. Invest New Drugs. 1990 Nov;8(4):385-6. doi: 10.1007/BF00198596. Invest New Drugs. 1990. PMID: 1964676 Clinical Trial. No abstract available.

9

Phase II evaluation of recombinant gamma-interferon in patients with advanced pancreatic carcinoma: a Southwest Oncology Group study.

Von Hoff DD, Fleming TR, Macdonald JS, Goodman PJ, Van Damme J, Brown TD, O'Rourke T, Feun LG, Keppen MD. Von Hoff DD, et al. J Biol Response Mod. 1990 Dec;9(6):584-7. J Biol Response Mod. 1990. PMID: 2127424 Clinical Trial.

10

Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin.

Von Hoff DD, Sarosy G, Brown TD, Kuhn JG, Kisner DL. Von Hoff DD, et al. Semin Oncol. 1986 Sep;13(3 Suppl 2):72-7. Semin Oncol. 1986. PMID: 3764442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

772 results

Search Page

Filters